Malvern, Pennsylvania, United States · Est. 1991 · 1,000 employees
Endo Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing branded and generic pharmaceuticals for pain management, aesthetics, and other specialized therapeutic areas.
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Earlier
Details
Company Overview
$100.0M
Mkt Cap
$700.0M
Revenue
—
Cash
Therapeutic Focus
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)